Effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy: the Rosiglitazone Early Versus SULphonylurea Titration (RESULT) Study.

Abstract

Practice Pearl: This study demonstrates the effectiveness of the early addition of rosiglitazone to control hyperglycemia after unsuccessful submaximal sulphonylurea monotherapy. Original Article: Rosenstock J, Goldstein BJ, Vinik AI, et al. RESULT Study Group. Effect of early addition of rosiglitazone to sulphonylurea therapy in older type 2 diabetes patients (> 60 years): the Rosiglitazone Early vs. SULphonylurea Titration (RESULT) study.

• Authors: Amit Agrawal
• Journal: The Physician and sportsmedicine (Phys Sportsmed) Vol. 37 Issue 1 Pg. 146-8 (Apr 2009) ISSN: 0091-3847 [Print] England
• PMID: 20048503 (Publication Type: Journal Article)

Chemical References

• Blood Glucose
• Glycated Hemoglobin A
• Hypoglycemic Agents
• Thiazolidinediones
• Triglycerides
• Rosiglitazone
• Cholesterol
• Glipizide

Topics

• Age Factors
• Blood Glucose (analysis)
• Cholesterol (blood)
• Diabetes Mellitus, Type 2 (drug therapy, metabolism)
• Disease Progression
• Double-Blind Method
• Drug Administration Schedule
• Drug Therapy, Combination
• Female
• Glipizide (administration & dosage, adverse effects)
• Glycated Hemoglobin
• Humans
• Hypoglycemic Agents (administration & dosage, adverse effects)
• Insulin Resistance
• Liver (enzymology)
• Male
• Middle Aged
• Randomized Controlled Trials as Topic
• Rosiglitazone
• Thiazolidinediones (adverse effects, therapeutic use)
• Titrimetry
• Treatment Outcome
• Triglycerides (blood)